Antimicrobial resistance (AMR) is increasingly emerging as a serious global economic risk, with the World Health Organization (WHO) projecting that it could add up to US$1 trillion in global healthcare costs by 2050. Reflecting the growing urgency, AMR will take centre stage at the AMR Leaders’ Summit, scheduled for 12–13 February at WHX Labs in Dubai (formerly Medlab Middle East).
Understanding AMR and Its Impact on Healthcare
AMR develops when bacteria and other microbes become resistant to medicines such as antibiotics, making treatments less effective—or, in some cases, completely ineffective. As a result, healthcare systems face longer hospital stays, higher complication rates, and increased mortality. Consequently, hospitals, insurers, and governments experience mounting pressure on capacity, resources, and budgets.
Economic Consequences Extend Beyond Healthcare
Beyond clinical settings, the economic implications of AMR are equally severe. The World Bank estimates that uncontrolled AMR could reduce global GDP by 3.8% annually by 2050 and push 28 million people into poverty. Therefore, governments, employers, and healthcare leaders must recognise AMR as a long-term threat to productivity, economic resilience, and sustainable growth.
Antibiotics: A Medical Breakthrough Under Threat
Highlighting the historical significance of antibiotics, Dr Wael Elamin, Medical Director, Environmental Sciences, M42, and Chair of the AMR Leaders’ Summit, noted that antibiotics remain one of medicine’s greatest breakthroughs. “Historically, most people died young or around the age of 50, mainly due to infections. Antibiotics have added more life years per dollar than any other health investment,” he said.
Overuse Accelerates Resistance and Erodes Gains
However, Dr Elamin warned that widespread and indiscriminate antibiotic use is accelerating AMR and steadily eroding the benefits antibiotics have delivered. As infections become harder and more expensive to treat, healthcare systems face growing operational and financial strain.
Hospital Outbreaks Carry Heavy Financial Costs
Moreover, outbreaks of drug-resistant infections can impose significant financial losses on hospitals. Dr Elamin cited a case involving a multidrug-resistant Acinetobacter outbreak in a UK burns intensive care unit, which forced the facility to close for several days, leading to high direct costs and lost revenue. Similar disruptions, he noted, are occurring with increasing frequency across hospitals worldwide.
The One Health Approach Gains Importance
In addition to healthcare misuse, AMR is fuelled by the overuse of antibiotics in agriculture, which remains the largest global consumer of these drugs. At the AMR Leaders’ Summit, experts will emphasise the “One Health” approach, recognising the interconnectedness of human health, animal health, and environmental practices. Reducing AMR, they stress, requires coordinated action across all three domains.
Innovation and Technology Offer Pathways Forward
Looking ahead, Dr Elamin underscored the importance of rapid diagnostic tools capable of distinguishing bacterial from viral infections, alongside continued investment in new antibiotics. He also highlighted the growing role of artificial intelligence, which is already showing promise in accelerating the development of next-generation treatments.
AMR Leaders’ Summit to Drive Action-Oriented Dialogue
As a flagship launch for WHX Labs in Dubai 2026, the AMR Leaders’ Summit will bring together scientists, clinicians, policymakers, and innovators to bridge the gap between research and real-world implementation. Held under the theme “Policy. Technology. Solutions. Tackling AMR”, the summit will combine global expertise with region-specific insights tailored to the GCC and wider MENA region.
Platform for Policy, Funding, and Partnerships
Commenting on the initiative, Tom Coleman, Portfolio Director, Informa Markets, said the AMR Leaders’ Summit represents the first GCC-based AMR launch within a global diagnostics event. “This gives it the technical depth and policy reach needed to drive real change. Crucially, it is an outcome-driven platform focused on concrete commitments, funding models, and cross-sector partnerships that can deliver impact in this region and beyond,” he said.
WHX Labs Dubai Marks 25 Years of Innovation
Meanwhile, WHX Labs in Dubai, the region’s leading laboratory and diagnostics event, will take place at the Dubai World Trade Centre from 10–13 February, under the patronage of the UAE Ministry of Health and Prevention. This patronage reinforces the nation’s commitment to delivering world-class healthcare.
Marking 25 years of success, WHX Labs Dubai will run under the theme “25 years of laboratory innovation: Uniting communities for better health”, showcasing global excellence in laboratory medicine, diagnostics, and precision healthcare.
World Health Expo Runs in Parallel
WHX Labs in Dubai will coincide with the World Health Expo (WHX) in Dubai, scheduled from 9–12 February at the Dubai Exhibition Centre, further strengthening the city’s position as a global hub for healthcare innovation.